Register information Patent

DE file number : 60 2009 048 797.3 (Status: pending/in force, Query started: May 4, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INID	Criterion	Field	Content
	Type of IP right	SART	Patent
	Status	ST	Pending/in force
21	DE file number	DAKZ	60 2009 048 797.3
96	EP file number	EAKZ	09 73 4929.4
86	WO file number	WAKZ	PCT/US2009/002536
97	EP publication number	EPN	2310415
87	WO publication number	WPN	2009131702
54	Designation/title	TI	ANTIKÖRPER GEGEN FCRN UND DEREN VERWENDUNG
51	IPC main class	ICM (ICMV)	C07K 16/28 (2006.01)
51	IPC secondary class(es)	ICS (ICSV)	G01N 33/68 (2006.01)
22	DE application date	DAT	Apr 24, 2009
96	EP application date	EAT	Apr 24, 2009
86	WO application date	WAT	Apr 24, 2009
43	Date of first publication	OT	Oct 29, 2009
	Date of publication of grant	PET	Oct 11, 2017
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72	Inventor	IN	TENHOOR, Christopher, HopkintonMA 01748, US; MURUGANANDAM, Arumugam, Bangalore 560035, IN; LADNER, Robert, Charles, IjamsvilleMD 21754, US; WOOD, Clive, Boston, MA 02114, US; BITONTI, Alan, J., ActonMA 01720, US; STATTEL, James, HagerstownMD 21740, US; MCDONNELL, Kevin, WalthamMA 02451, US; LIU, Liming, Upper DublinPA 19002, US; DUMONT, Jennifer, GrotonMA 01450, US; SATO, Aaron, RichmondCA 94805, US
	Address for service		RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33 31 32	Foreign priority	PRC PRNA PRDA	US 48152 P Apr 25, 2008
33 31 32	Foreign priority	PRC PRNA PRDA	US 48500 P Apr 28, 2008
	Due date	FT FG	Apr 30, 2026 Annual fee for the 18th year Patent fees
	Patent division in charge		44
97	EP language of publication	ELANG	EN - Englisch
84	Designated EP contracting states	EDS	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
81	Designated WO countries	WDS	AL, RS, BA
	Published EP/WO documents	EPWOPN	Original document: EP000002310415 Searchable text: EP000002310415 Original document: EP000002310415B1 Searchable text: EP000002310415B1 Original document: WO002009131702 Searchable text: WO002009131702
43	Date of first publication	EVT	Oct 29, 2009
	Date of the first transfer into DPMAregister	EREGT	May 31, 2011
	Date of the (most recent) update in DPMAregister	REGT	Mar 28, 2025 (Show all update days)(Hide all update days) Mar 28, 2025 Due date: changed May 9, 2024; Mar 27, 2024; Mar 28, 2023; Jul 30, 2022; Mar 30, 2022; Nov 18, 2021; Oct 9, 2021; Mar 31, 2021; Mar 25, 2020; Aug 21, 2019; Mar 28, 2019; Feb 28, 2019; Nov 28, 2018; Nov 15, 2018; Oct 16, 2018; Oct 9, 2018; Oct 4, 2018; Sep 13, 2018; Aug 30, 2018; Mar 24, 2018; Nov 28, 2017; Nov 9, 2017; Oct 18, 2017; Oct 12, 2017; May 4, 2017; Nov 9, 2016; Feb 15, 2013; Jul 27, 2011; Jun 9, 2011 Historical data not available for this/these date(s) May 31, 2011 Date of the first transfer into DPMAregister

Procedural data
No.	Kind of procedure	Legal status	Date of legal/procedural status	Publication date	Alle Details anzeigen
1	Procedure relating to PCT application	WO first publication without search report	Oct 29, 2009		Details anzeigen
2	Procedure relating to PCT application	WO publication	Oct 29, 2009		Details anzeigen
3	Procedure relating to EP application	EPO 1st publication	Apr 20, 2011		Details anzeigen
4	Publications	Publication of a mention regarding EP 1st publication by DPMA	Jun 1, 2011	Jun 1, 2011	Details anzeigen
5	Change of classification	Change of IPC main class	Oct 4, 2016		Details anzeigen
6	Procedure relating to EP application	EPO publication of mention regarding patent grant (beginning of opposition period)	Oct 11, 2017		Details anzeigen
7	Publications	Publication by DPMA of mention regarding EP patent grant	Nov 23, 2017	Nov 23, 2017	Details anzeigen
8	New applicant/owner details	New applicant/owner details	Nov 27, 2017	Nov 15, 2018	Details anzeigen
9	Procedure relating to EP application	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision	Jul 12, 2018	Oct 4, 2018	Details anzeigen
10	New applicant/owner details	New applicant/owner details	Oct 8, 2018	Nov 15, 2018	Details anzeigen
11	New applicant/owner details	New applicant/owner details	Oct 15, 2018	Nov 22, 2018	Details anzeigen
12	New applicant/owner details	New applicant/owner details	Oct 8, 2021	Nov 18, 2021	Details anzeigen

View procedures Procedure relating to PCT application (No.: 1)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to PCT application
Legal/procedural status	VST	WO first publication without search report
Date of legal/procedural status	VSTT	Oct 29, 2009

View procedures Procedure relating to PCT application (No.: 2)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to PCT application
Legal/procedural status	VST	WO publication
Date of legal/procedural status	VSTT	Oct 29, 2009

View procedures Procedure relating to EP application (No.: 3)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO 1st publication
Date of legal/procedural status	VSTT	Apr 20, 2011

View procedures Publications (No.: 4)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural status	VSTT	Jun 1, 2011
Issue number	HN	22
Year	PJ	2011
Publication date	VT	Jun 1, 2011
Type of publication	PART	Bibliographic data

View procedures Change of classification (No.: 5)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	Change of classification
	Legal/procedural status	VST	Change of IPC main class
	Date of legal/procedural status	VSTT	Oct 4, 2016
51	IPC main class	ICM (ICMV)	C07K 16/28 (2006.01)
51	Previous IPC main class	ICMF (ICMVF)	C07K 16/28 (2006.01)

View procedures Procedure relating to EP application (No.: 6)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	EPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural status	VSTT	Oct 11, 2017

View procedures Publications (No.: 7)
Criterion	Field	Content Close details
Type of procedure	VART	Publications
Legal/procedural status	VST	Publication by DPMA of mention regarding EP patent grant
Date of legal/procedural status	VSTT	Nov 23, 2017
Issue number	HN	47
Year	PJ	2017
Publication date	VT	Nov 23, 2017
Type of publication	PART	Bibliographic data
Part	HT	Part 5

View procedures New applicant/owner details (No.: 8)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Nov 27, 2017
	Issue number	HN	46
	Year	PJ	2018
	Publication date	VT	Nov 15, 2018
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Biogen Hemophilia Inc., Waltham, Mass., US; Dyax Corp., Burlington, Mass., US
71/73	Previous applicant/owner	INHF	Biogen Hemophilia Inc., Waltham, Mass., US, Dyax Corp., Cambridge, Mass., US

View procedures Procedure relating to EP application (No.: 9)
Criterion	Field	Content Close details
Type of procedure	VART	Procedure relating to EP application
Legal/procedural status	VST	No opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural status	VSTT	Jul 12, 2018
Issue number	HN	40
Year	PJ	2018
Publication date	VT	Oct 4, 2018
Type of publication	PART	Bibliographic data
Part	HT	Part 3

View procedures New applicant/owner details (No.: 10)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Oct 8, 2018
	Issue number	HN	46
	Year	PJ	2018
	Publication date	VT	Nov 15, 2018
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Dyax Corp., Cambridge, Mass., US
71/73	Previous applicant/owner	INHF	Biogen Hemophilia Inc., Waltham, Mass., US, Dyax Corp., Burlington, Mass., US

View procedures New applicant/owner details (No.: 11)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Oct 15, 2018
	Issue number	HN	47
	Year	PJ	2018
	Publication date	VT	Nov 22, 2018
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Dyax Corp., Burlington, Mass., US
71/73	Previous applicant/owner	INHF	Bioverativ Therapeutics Inc., Waltham, Mass., US, Dyax Corp., Cambridge, Mass., US
	Date of update of the procedure	REGT	Jul 30, 2022

View procedures New applicant/owner details (No.: 12)
INID	Criterion	Field	Content Close details
	Type of procedure	VART	New applicant/owner details
	Legal/procedural status	VST	New applicant/owner details
	Date of legal/procedural status	VSTT	Oct 8, 2021
	Issue number	HN	46
	Year	PJ	2021
	Publication date	VT	Nov 18, 2021
	Type of publication	PART	Bibliographic data
	Part	HT	Part 3
71/73	Applicant/owner	INH	Bioverativ Therapeutics Inc., Waltham, Mass., US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73	Previous applicant/owner	INHF	Bioverativ Therapeutics Inc., Waltham, Mass., US, Dyax Corp., Burlington, Mass., US
	Date of update of the procedure	REGT	Nov 18, 2021